Network Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Products (I-STAT, Accu-Chek Inform II, StatStrip, Homecue, CareSens Expert Plus, Barozen H Expert Plus) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Network Point-of-Care Glucose Testing Market Size

The global network point-of-care glucose testing market size was valued at USD 1.42 billion in 2025 and is projected to grow from USD 1.47 billion in 2026 to USD 1.94 billion by 2034, registering a CAGR of 3.5% during the forecast period from 2026 to 2034. North America dominated the network point-of-care glucose testing market with a market share of 38% in 2025.

A large senior population, affordable healthcare facilities, cheap labor, and relatively less stringent regulatory policies are among the factors compelling diabetic device manufacturers to expand their businesses, stimulating network point-of-care glucose testing market growth.

Network Point of Care Glucose Testing refers to a system or approach in which glucose testing is conducted at the point of care, typically in healthcare settings like hospitals, clinics, or physician offices. It uses interconnected devices and network infrastructure to enable real-time communication and data sharing between healthcare providers, patients, and laboratory systems. The main objective of Network Point of Care Glucose Testing is to provide healthcare professionals with immediate access to accurate and up-to-date glucose level information for efficient diabetes management. It allows for the timely monitoring of glucose levels, adjustment of treatment plans, and prompt intervention if necessary. This approach is particularly valuable for individuals with diabetes, as it enables personalized care and facilitates better glycemic control.

Network Point of Care Glucose Testing typically involves using portable glucose meters or testing devices that can provide instant results. These devices are connected to a network, allowing the test results to be transmitted and stored in a central database or electronic health record system. Healthcare providers can access the data remotely, review the glucose levels, and make informed decisions regarding patient care. By implementing Network Point of Care Glucose Testing, healthcare professionals can closely monitor glucose levels in real-time, reducing the need for delayed laboratory testing and providing immediate patient feedback. This can lead to improved patient outcomes, better management of diabetes-related complications, and enhanced patient satisfaction.

Products Insights

The global network point-of-care glucose testing market is bifurcated into I-STAT, accu-chek inform II, statstrip, Homecue, Caresens Expert Plus, and Barozen h expert plus. The I-STAT segment dominates the global market and is projected to exhibit a CAGR of 3.8% over the forecast period. I-STAT portable clinical analyzer developed by Abbott is one of the POC analyzers used at patients’ bedside for critical care tests for electrolytes, coagulation, blood gases, and metabolites. The device is equipped with several testing cartridges for monitoring different sets of analytes, which eliminates the need for several analyzers for different analytes.

The Accu-Chek Inform II glucose meter is designed for in vitro diagnostic applications aiding in determining blood glucose levels. This glucose meter monitors blood glucose levels in capillary, venous, neonatal, arterial, and whole blood samples. Healthcare professionals adopt Accu-Chek Inform II, as it serves as a bedside system that aids in the measurement of glucose and automates the management of data generated by blood glucose tests. This helps healthcare professionals offer quality patient care. The table below enlists the properties and features of the Accu-Chek Inform II glucose meter.

Request Customizationto receive a tailored report.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global network point-of-care glucose testing market shareholder and is estimated to grow at a CAGR of 4.8% over the forecast period. North America generated the highest revenue in the global Point-Of-Care (nPOC) glucose diagnostics/testing market in 2022 and is forecasted to maintain its dominance over the forecast period. This region has several key market players, such as Abbott, Nova Biomedical, and Prodigy Diabetes Care, LLC. This has increased the availability of glucose-testing products, contributing to revenue generation. In addition, higher healthcare expenditure by governments on diabetes management is one of the factors responsible for the largest share held by the region in the global market.

Furthermore, local manufacturers are continuously evolving in terms of technological advancements. They are incorporating the latest technologies, such as Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMR), expected to drive the market growth during the forecast period. Research studies performed on analyzing glucose POC testing compliances offer useful insights for users. For example, according to a research article published by the American Association for Clinical Chemistry in 2018, collaboration and data sharing with leading medical settings ensure the compliant use of novel glucose testing products.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Network Point-of-Care Glucose Testing Market Trends

Europe is anticipated to exhibit a CAGR of 7.2% over the forecast period. The demand for POC glucose testing in Europe is fueled by the need for quick and reliable diagnostic tools to provide immediate results at the point of care. POC testing allows healthcare professionals to make timely decisions regarding treatment plans and interventions, improving patient outcomes. With the rising burden of diabetes in Europe, there is a growing recognition of the importance of early detection and proactive management of the condition.

Furthermore, POC glucose testing plays a crucial role in achieving this goal. Local players in Europe have made notable contributions to the revenue of the POC glucose testing market. Companies such as HemoCue AB, headquartered in Sweden, have developed diverse product portfolios catering to the European market's specific needs. HemoCue AB specializes in POC diagnostics and offers innovative testing solutions for the better management of diabetes. Their products provide accurate and rapid glucose testing, enabling healthcare professionals to make informed decisions and provide appropriate patient care.

Asia Pacific Network Point-of-Care Glucose Testing Market Trends

In Asia Pacific, the adoption of POC tests is rapidly increasing owing to their advantages, such as fast, easy, and mobile diagnosis and self-monitoring. These products facilitate patient diagnosis and monitoring at hospitals, health assessment centers, clinics, and homes. Developing healthcare infrastructure and the high prevalence of diabetes are among the factors expected to drive market growth in Asia-Pacific countries.

Furthermore, the rise in the adoption of miniaturized models and various measures to reduce hospital and clinic stays are expected to boost the demand for POC glucose testing products. Adoption of POC glucose diagnostics in operating rooms, emergency rooms, intensive care units, path labs, and hospitals is expected to increase owing to the early and efficient delivery of results.

In Latin America, POC tests are associated with clinical diagnostics and self-monitoring in the current market scenario. POC products are used for diagnosis and monitoring in hospitals, clinics, health assessment centers, and at home. These products are usually portable and mobile for performing tests at almost any location, thus boosting the adoption rate of these products. Increasing government spending, the rising focus of key multinational market players in this region, and growing patient awareness are among the factors expected to drive market growth over the forecast period.

List of Key and Emerging Players in Network Point-of-Care Glucose Testing Market